Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
J Cancer Res Clin Oncol ; 134(8): 833-9, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18264722

RESUMEN

Proper activation of phosphoinositide 3-kinase-Akt pathway is critical for the prevention of tumorigenesis. Recent data have characterized a negative feedback loop, wherein mammalian target of rapamycin (mTOR) blocks additional activation of the Akt/mTOR pathway through inhibition insulin receptor substrate 1 (IRS-1) function. However, the potential of IRS-1 inhibition during rapamycin treatment has not been examined. Herein, we show that IRS-1 antisense oligonucleotide and rapamycin synergistically antagonize the activation of mTOR in vivo and induced tumor suppression, through inhibition of proliferation and induction of apoptosis, in prostate cancer cell xenografts. These data demonstrate that the addition of agents that blocks IRS-1 potentiate the effect of mTOR inhibition in the growth of prostate cancer cell xenografts.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/efectos de los fármacos , Antibióticos Antineoplásicos/farmacología , Neoplasias de la Próstata/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos , Sirolimus/farmacología , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Apoptosis/efectos de los fármacos , Western Blotting , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Humanos , Proteínas Sustrato del Receptor de Insulina , Masculino , Ratones , Ratones SCID , Fosforilación/efectos de los fármacos , Neoplasias de la Próstata/metabolismo , Proteínas Quinasas/efectos de los fármacos , Proteínas Quinasas/metabolismo , Serina-Treonina Quinasas TOR , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Endocrinology ; 148(11): 5220-9, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17717055

RESUMEN

The pathogenesis of cancer anorexia is multifactorial and associated with disturbances of the central physiological mechanisms controlling food intake. However, the neurochemical mechanisms responsible for cancer-induced anorexia are unclear. Here we show that chronic infusion of 5-amino-4imidazolecarboxamide-riboside into the third cerebral ventricle and a chronic peripheral injection of 2 deoxy-d-glucose promotes hypothalamic AMP-activated protein kinase (AMPK) activation, increases food intake, and prolongs the survival of anorexic tumor-bearing (TB) rats. In parallel, the pharmacological activation of hypothalamic AMPK in TB animals markedly reduced the hypothalamic production of inducible nitric oxide synthase, IL-1beta, and TNF-alpha and modulated the expression of proopiomelanocortin, a hypothalamic neuropeptide that is involved in the control of energy homeostasis. Furthermore, the daily oral and intracerebroventricular treatment with biguanide antidiabetic drug metformin also induced AMPK phosphorylation in the central nervous system and increased food intake and life span in anorexic TB rats. Collectively, the findings of this study suggest that hypothalamic AMPK activation reverses cancer anorexia by inhibiting the production of proinflammatory molecules and controlling the neuropeptide expression in the hypothalamus, reflecting in a prolonged life span in TB rats. Thus, our data indicate that hypothalamic AMPK activation presents an attractive opportunity for the treatment of cancer-induced anorexia.


Asunto(s)
Anorexia/etiología , Complejos Multienzimáticos/fisiología , Neoplasias/complicaciones , Neuronas/metabolismo , Proteínas Serina-Treonina Quinasas/fisiología , Proteínas Quinasas Activadas por AMP , Aminoimidazol Carboxamida/administración & dosificación , Aminoimidazol Carboxamida/análogos & derivados , Aminoimidazol Carboxamida/farmacología , Animales , Anorexia/enzimología , Desoxiglucosa/administración & dosificación , Desoxiglucosa/farmacología , Vías de Administración de Medicamentos , Hipotálamo/efectos de los fármacos , Hipotálamo/enzimología , Hipotálamo/metabolismo , Masculino , Metformina/administración & dosificación , Metformina/farmacología , Complejos Multienzimáticos/metabolismo , Trasplante de Neoplasias , Neoplasias/enzimología , Neoplasias/mortalidad , Neoplasias/patología , Neuronas/enzimología , Fosforilación , Proteínas Serina-Treonina Quinasas/metabolismo , Ratas , Ratas Wistar , Ribonucleótidos/administración & dosificación , Ribonucleótidos/farmacología , Análisis de Supervivencia , Células Tumorales Cultivadas
4.
J Physiol ; 577(Pt 3): 997-1007, 2006 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-17008371

RESUMEN

Lifestyle interventions including exercise programmes are cornerstones in the prevention of obesity-related diabetes. In this study, we demonstrate that a single bout of exercise inhibits high-fat diet-induced insulin resistance. Diet-induced obesity (DIO) increased the expression and activity of the protein tyrosine phosphatase 1B (PTP1B) and attenuated insulin signalling in gastrocnemius muscle of rats, a phenomenon which was reversed by a single session of exercise. In addition, DIO was observed to lead to serine phosphorylation of insulin receptor substrate 1 (IRS-1), which was also reversed by exercise in muscle in parallel with a reduction in c-Jun N-terminal kinase (JNK) activity. Thus, acute exercise increased the insulin sensitivity during high-fat feeding in obese rats. Overall, these results provide new insights into the mechanism by which exercise restores insulin sensitivity.


Asunto(s)
Grasas de la Dieta/administración & dosificación , Resistencia a la Insulina , Obesidad/fisiopatología , Fosfoproteínas/química , Fosfoproteínas/metabolismo , Condicionamiento Físico Animal , Proteínas Tirosina Fosfatasas/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Proteínas I-kappa B/antagonistas & inhibidores , Insulina/metabolismo , Proteínas Sustrato del Receptor de Insulina , Proteínas Quinasas JNK Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Masculino , Músculo Esquelético/metabolismo , Obesidad/etiología , Obesidad/metabolismo , Fosforilación , Proteína Tirosina Fosfatasa no Receptora Tipo 1 , Ratas , Ratas Wistar , Recuperación de la Función , Serina/metabolismo , Transducción de Señal , Natación
5.
Diabetes ; 55(9): 2554-61, 2006 09.
Artículo en Inglés | MEDLINE | ID: mdl-16936204

RESUMEN

Prolonged exercise of medium to high intensity is known to promote a substantial effect on the energy balance of rats. In male rats, moderately to severely intense programs lead to a reduction in food intake. However, the exact causes for the appetite-suppressive effects of exercise are not known. Here, we show that intracerebroventricular insulin or leptin infusion reduced food intake in exercised rats to a greater extent than that observed in control animals. Exercise was associated with a markedly increased phosphorylation/activity of several proteins involved in leptin and insulin signal transduction in the hypothalamus. The regulatory role of interleukin (IL)-6 in mediating the increase in leptin and insulin sensitivity in hypothalamus was also investigated. Treatment with insulin or leptin markedly reduced food intake in exercised rats that were pretreated with vehicle, although no increase in sensitivity to leptin- and insulin-induced anorexia after pretreatment with anti-IL-6 antibody was detected. The current study provides direct measurements of leptin and insulin signaling in the hypothalamus and documents increased sensitivity to these hormones in the hypothalamus of exercised rats in an IL-6-dependent manner. These findings provide support for the hypothesis that the appetite-suppressive actions of exercise may be mediated by the hypothalamus.


Asunto(s)
Hipotálamo/fisiología , Insulina/fisiología , Interleucina-6/fisiología , Leptina/fisiología , Condicionamiento Físico Animal/fisiología , Animales , Glucemia/metabolismo , Ingestión de Alimentos/efectos de los fármacos , Activación Enzimática , Inyecciones Intraventriculares , Insulina/sangre , Proteínas Sustrato del Receptor de Insulina , Janus Quinasa 2 , Leptina/sangre , Masculino , Fosfatidilinositol 3-Quinasas/fisiología , Fosfoproteínas/fisiología , Proteínas Tirosina Quinasas/fisiología , Proteínas Proto-Oncogénicas/fisiología , Ratas , Ratas Wistar , Factor de Transcripción STAT3/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA